MIM
NEXI

MetLife Investment Management’s NexImmune, Inc. Common Stock NEXI Stock Holding History

MetLife Investment Management’s Portfolio NEXI Stock Details NEXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-308
Closed -$117K – 2566
2021
Q3 		$117K Buy
+308
New +$103K ﹤0.01% 2372

Other funds holding NEXI

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AO
Allen Operations New York $722M AUM 20.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

MetLife Investment Management's NEXI Position: Q4 2021 in Review

MetLife Investment Management sold out of NexImmune, Inc. Common Stock (NEXI) in Q4 2021, closing a stake of 308 shares — an estimated $117K sold.

MetLife Investment Management first reported a position in NEXI in Q3 2021 and held it in 1 quarter. The position peaked at $117K in Q3 2021. 46 funds tracked by Wall St. Rank hold NEXI as of Q4 2021.

  • MetLife Investment Management reported no remaining NexImmune, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • MetLife Investment Management sold 308 NexImmune, Inc. Common Stock shares in Q4 2021, an estimated $117K.
  • MetLife Investment Management first reported a position in NexImmune, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • MetLife Investment Management's NexImmune, Inc. Common Stock position peaked at $117K in Q3 2021.
  • 46 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q4 2021.

Based on MetLife Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.